Aligos Therapeutics, Inc.

NASDAQ:ALGS

39.34 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -87.679-96.046-128.332-108.543-52.264-13.933
Depreciation & Amortization 3.0693.6753.7783.3252.2991.291
Deferred Income Tax 0000.530-0.11
Stock Based Compensation 12.65214.69313.4572.9750.7520.179
Change In Working Capital -9.525-1.552-4.65116.0633.6714.885
Accounts Receivables 000000
Inventory 000000
Accounts Payables -2.2191.722-0.313-0.130.3852.977
Other Working Capital -7.306-3.274-4.33816.1933.2861.908
Other Non Cash Items 2.486-0.1590.08611.387-1.2251.639
Operating Cash Flow -78.997-79.389-115.662-74.263-46.767-6.049
Investing Activities:
Investments In Property Plant And Equipment -0.019-0.943-0.892-2.064-2.786-2.516
Acquisitions Net 025.35-3.914-34.819-9.5770
Purchases Of Investments -0.011-104.265-19.086-45.281-70.423-66.773
Sales Maturities Of Investments 45.01178.9152380.1800
Other Investing Activites 0-25.353.91434.8199.577-72.843
Investing Cash Flow 44.981-26.2933.02232.7556.791-69.289
Financing Activities:
Debt Repayment -0.096-0.061-0.079-0.058-0.0435
Common Stock Issued 17.4430.0278.584155.54285.5750.002
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 70.9810.2250.1724085.57594.883
Financing Cash Flow 88.3280.16478.677192.34885.53299.885
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 54.312-105.518-33.963150.8445.55624.547
Cash At End Of Period 135.77481.462186.98220.94370.10324.547